OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Recent Advances in Perioperative Immunotherapies in Lung Cancer
Shota Fukuda, Kenichi Suda, Akira Hamada, et al.
Biomolecules (2023) Vol. 13, Iss. 9, pp. 1377-1377
Open Access | Times Cited: 6
Shota Fukuda, Kenichi Suda, Akira Hamada, et al.
Biomolecules (2023) Vol. 13, Iss. 9, pp. 1377-1377
Open Access | Times Cited: 6
Showing 6 citing articles:
Immunotherapy for advanced-stage squamous cell lung cancer: the state of the art and outstanding questions
Yibei Wang, Mohammed Safi, Fred R. Hirsch, et al.
Nature Reviews Clinical Oncology (2025) Vol. 22, Iss. 3, pp. 200-214
Closed Access | Times Cited: 1
Yibei Wang, Mohammed Safi, Fred R. Hirsch, et al.
Nature Reviews Clinical Oncology (2025) Vol. 22, Iss. 3, pp. 200-214
Closed Access | Times Cited: 1
Resistance in Lung Cancer Immunotherapy and How to Overcome It: Insights from the Genetics Perspective and Combination Therapies Approach
Paweł Zieliński, Maria Stępień, Hanna Chowaniec, et al.
Cells (2025) Vol. 14, Iss. 8, pp. 587-587
Open Access
Paweł Zieliński, Maria Stępień, Hanna Chowaniec, et al.
Cells (2025) Vol. 14, Iss. 8, pp. 587-587
Open Access
Neoadjuvant and Adjuvant Immunotherapy in Resectable NSCLC
Evangelia Bogatsa, George Lazaridis, Chrysoula Stivanaki, et al.
Cancers (2024) Vol. 16, Iss. 9, pp. 1619-1619
Open Access | Times Cited: 2
Evangelia Bogatsa, George Lazaridis, Chrysoula Stivanaki, et al.
Cancers (2024) Vol. 16, Iss. 9, pp. 1619-1619
Open Access | Times Cited: 2
Perioperative Immune Checkpoint Blockade for Muscle-Invasive and Metastatic Bladder Cancer
Chethan Ramamurthy, Karen Wheeler, Shaun Trecarten, et al.
Journal of Cancer Immunology (2024) Vol. 6, Iss. 1, pp. 29-39
Open Access | Times Cited: 2
Chethan Ramamurthy, Karen Wheeler, Shaun Trecarten, et al.
Journal of Cancer Immunology (2024) Vol. 6, Iss. 1, pp. 29-39
Open Access | Times Cited: 2
Real-World Treatment Patterns and Timeliness of Clinical Care Pathway for Non-Small Cell Lung Cancer Patients in Austria: The PRATER Retrospective Study
Maximilian J. Hochmair, Angelika Terbuch, David Lang, et al.
Cancers (2024) Vol. 16, Iss. 14, pp. 2586-2586
Open Access | Times Cited: 1
Maximilian J. Hochmair, Angelika Terbuch, David Lang, et al.
Cancers (2024) Vol. 16, Iss. 14, pp. 2586-2586
Open Access | Times Cited: 1
Clinical factors associated with high PD ‐L1 expression in patients with early‐stage non‐small cell lung cancer
Shuta Ohara, Kenichi Suda, Akira Hamada, et al.
Thoracic Cancer (2024) Vol. 15, Iss. 31, pp. 2229-2234
Open Access | Times Cited: 1
Shuta Ohara, Kenichi Suda, Akira Hamada, et al.
Thoracic Cancer (2024) Vol. 15, Iss. 31, pp. 2229-2234
Open Access | Times Cited: 1
The Clinical Outcomes of Thoracoscopic Versus Open Lobectomy for Non–Small-Cell Lung Cancer After Neoadjuvant Therapy: A Multi-Center Retrospective Cohort Study
Jinglin Cao, Chong Zhang, Xun Zhang, et al.
Clinical Lung Cancer (2023) Vol. 25, Iss. 3, pp. e153-e160
Closed Access
Jinglin Cao, Chong Zhang, Xun Zhang, et al.
Clinical Lung Cancer (2023) Vol. 25, Iss. 3, pp. e153-e160
Closed Access
